VITASORA HEALTH LIMITED - Announcements

0.00%

2.6¢

Market Cap $44.68M

Technology Scientific & Technical Instruments

Vitasora Health Limited, formerly Respiri Limited, is an Australia-based healthcare... Vitasora Health Limited, formerly Respiri Limited, is an Australia-based healthcare technology and services company that focuses on digital Connected Care in the United States healthcare market. The Company offers remote patient monitoring (RPM) and chronic care management (CCM) services. Its Care Management model enables healthcare organizations to extend care beyond their clinics, integrating multi-device remote monitoring, virtual clinical support, and artificial intelligence (AI)-powered decision-making.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

VHL	Change of Company Name		02/12/14	291.14KB	Share
VHL	Results of Meeting - 2014		28/11/14	162.52KB	Share
VHL	Results of Meeting - 2013 meeting		28/11/14	418KB	Share
VHL	Results of Meeting - 2012 meeting		28/11/14	146.43KB	Share
VHL	VHL boosts leadership with key chair and board appointments		28/11/14	184.14KB	Share
VHL	Virax Shareholder Newsletter		07/11/14	1.32MB	Share
VHL	Annual Report to shareholders		03/11/14	1.28MB	Share
VHL	Appendix 4C - quarterly	PRICE SENSITIVE	03/11/14	241.39KB	Share
VHL	ASX Grants Waiver - Listing Rule 10.13.3		31/10/14	440.1KB	Share
VHL	Company overview brochure		30/10/14	144.18KB	Share
VHL	Notice of AGM, including Independent Experts Report		30/10/14	973.78KB	Share
VHL	Notice of Annual General Meeting/Proxy Form		29/10/14	581.8KB	Share
VHL	Notices of AGM in relation to the 2012 and 2013 years		29/10/14	772.26KB	Share
VHL	Roadshow Presentation		28/10/14	2.27MB	Share
VHL	Video Presentation with Managing Director		17/10/14	430.94KB	Share
VHL	VHL TO ACQUIRE DEEP AKT INHIBITOR PORTFOLIO	PRICE SENSITIVE	17/10/14	517.4KB	Share
VHL	Trading Halt Request		15/10/14	434.08KB	Share
VHL	Trading Halt	PRICE SENSITIVE	15/10/14	135.24KB	Share
VHL	Multiple Myeloma Authority Joins Scientific Advisory Board		23/09/14	456.41KB	Share
VHL	FDA IND Re-Activation Request for Phase Ib/II Trial	PRICE SENSITIVE	09/09/14	441.65KB	Share
VHL	Virax Holdings Appendix 4E and 2014 Financial Report	PRICE SENSITIVE	01/09/14	1.44MB	Share
VHL	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/14	245.63KB	Share
VHL	Investor Roadshow Presentation		23/07/14	3.43MB	Share
VHL	Cancer Authority to help Steer US Breast Cancer Progam		21/07/14	458.79KB	Share
VHL	Initial Director's Interest Notice		24/06/14	195.67KB	Share
VHL	VHL appoints Ground Zero Pharmaceuticals		23/06/14	423.85KB	Share
VHL	New MD to Present at International Life Sciences Showcase		16/06/14	426.6KB	Share
VHL	Initial Director's Interest Notice		06/06/14	196.67KB	Share
VHL	VHL completes Pathway acquisiton, appoints new director	PRICE SENSITIVE	30/05/14	476.89KB	Share
VHL	Appendix 3B		30/05/14	541.98KB	Share
VHL	Appendix 3B		20/05/14	931.87KB	Share
VHL	Appointment of Managing Director to Drive Cancer Programs	PRICE SENSITIVE	15/05/14	497.36KB	Share
VHL	Appendix 3B		15/05/14	542.14KB	Share
VHL	Disclosure Document	PRICE SENSITIVE	14/05/14	835.15KB	Share
VHL	Capital Raising Update	PRICE SENSITIVE	09/05/14	427.69KB	Share
VHL	Results of Meeting		09/05/14	434.42KB	Share
VHL	Chairman's Address at General Meeting		09/05/14	169.01KB	Share
VHL	Investor Newsletter		06/05/14	552.49KB	Share
VHL	Virax Option to Acquire Exclusive Worldwide Licence	PRICE SENSITIVE	05/05/14	472.87KB	Share
VHL	Trading Halt	PRICE SENSITIVE	01/05/14	528.37KB	Share
VHL	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/14	239.03KB	Share
VHL	Appointment of Gene Tech expert to further develop assets		29/04/14	464.78KB	Share
VHL	Co-X-Gene Development Pipeline	PRICE SENSITIVE	24/04/14	452.49KB	Share
VHL	Notice of General Meeting/Proxy Form		08/04/14	236.89KB	Share
VHL	ASX Grants Waivers - Listing Rule 7.3.2		03/04/14	458.64KB	Share
VHL	Appendix 3B		27/03/14	541.54KB	Share
VHL	Virax secures $3 million placement	PRICE SENSITIVE	25/03/14	475.51KB	Share
VHL	Trading Halt	PRICE SENSITIVE	21/03/14	514.73KB	Share
VHL	Investor presentation		17/03/14	1.42MB	Share
VHL	Virax to acquire advanced cancer platform from Yale Uni	PRICE SENSITIVE	17/03/14	503.67KB	Share
VHL	Trading Halt	PRICE SENSITIVE	14/03/14	515.27KB	Share
VHL	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/14	701.92KB	Share
VHL	Intellectual Property Report Update	PRICE SENSITIVE	19/02/14	456.31KB	Share
VHL	Appendix 3B		18/02/14	541.51KB	Share
VHL	Response to ASX Aware Letter	PRICE SENSITIVE	12/02/14	664.29KB	Share
VHL	Transgene Announces Topline Preliminary Results	PRICE SENSITIVE	07/02/14	558.04KB	Share
VHL	Appendix 3B		11/12/13	541.54KB	Share
VHL	Company Update		05/12/13	548.72KB	Share
VHL	Reinstatement to Offical Quotation		19/11/13	424.27KB	Share
VHL	Response to ASX Appendix 3Z Query		19/11/13	546.56KB	Share
VHL	ASX Circular - Reinstatement to Official Quotation		18/11/13	84.19KB	Share
VHL	Reinstatement to Official Quotation - 19 November 2013	PRICE SENSITIVE	18/11/13	77.99KB	Share
VHL	Pre-quotation disclosures		14/11/13	1MB	Share
VHL	Retirement of Deed Administrator		14/11/13	426.23KB	Share
VHL	Annual Report for the Year Ended 30 June 2013		14/11/13	1.22MB	Share
VHL	Half Yearly Report for the period ended 31 December 2012		14/11/13	411.68KB	Share
VHL	Annual Report for the Year Ended 30 June 2012		14/11/13	1.79MB	Share
VHL	Administrator/Receiver ??? Appointed/Removed		13/11/13	20.88KB	Share
VHL	Change of Director's Interest Notices		29/10/13	1.16MB	Share
VHL	Final Director's Interest Notices		29/10/13	1.14MB	Share
VHL	Completion of Recapitalisation Proposal		25/10/13	458.96KB	Share
VHL	Company Secretary Appointment/Resignation		21/10/13	456.56KB	Share
VHL	Change in substantial holding		10/10/13	76.13KB	Share
VHL	Appendix 3B		25/09/13	514.89KB	Share
VHL	Prospectus		19/09/13	524.46KB	Share
VHL	Announcement of Updated Constitution		03/09/13	49.9KB	Share
VHL	Header Corr: Consolidation process as approved by Sh'holders		03/09/13	36.6KB	Share
VHL	Announcement of New Board/Appendix 3X Notices		03/09/13	181.74KB	Share
VHL	Internal		03/09/13	62.21KB	Share
VHL	Results of Meeting		02/09/13	203.82KB	Share
VHL	Details of Share Registry address		30/07/13	24.51KB	Share
VHL	Notice of General Meeting		30/07/13	2.81MB	Share
VHL	Company Administration - Other		28/02/13	22.46KB	Share
VHL	Execution of Deed of Company Arrangement		29/10/12	20.64KB	Share
VHL	Company Administration - Other		12/10/12	29.32KB	Share
VHL	Appointment of Voluntary Administrators 24 August 2012		24/08/12	119.31KB	Share
VHL	Convertible Note Quarterly Report 30 06 2012		31/07/12	244.62KB	Share
VHL	Appendix 3B - 15 June 2012		15/06/12	293.77KB	Share
VHL	Request for Continuation of Suspension		15/06/12	142.16KB	Share
VHL	Termination Share Purchase Agreement - 4G Vaccines Pty Ltd		15/06/12	101.73KB	Share
VHL	Co-X-Gene Sub Licence and TG4001		14/05/12	207.14KB	Share
VHL	Convertible Notes - Quarterly Report 31/3/2012		30/04/12	287.42KB	Share
VHL	Noteholder General Meeting Results - 30 March 2012		30/03/12	185.68KB	Share
VHL	Noteholder Notice of Meeting - 30 March 2012		15/03/12	1.46MB	Share
VHL	Appendix 4D (31 December 2011)		14/03/12	9.76MB	Share
VHL	Appointment of Director - Mr John Morrison - 13 March 2012		13/03/12	291.91KB	Share
VHL	Share Purchase Agreement - 4G Vaccines 29 February 2012		01/03/12	178.84KB	Share
AAY +AKW CBP COJ EDS HAO KZL SLA MTM VHL	Suspension from Official Quotation	PRICE SENSITIVE	01/03/12	16.4KB	Share
VHL	Convertible Notes - Quarterly Report 31 December 2011		31/01/12	366.47KB	Share
VHL	Appendix 3B - 10 January 2012		10/01/12	559.08KB	Share

VHL Change of Company Name
02/12/14		291.14KB	Share
VHL Results of Meeting - 2014
28/11/14		162.52KB	Share
VHL Results of Meeting - 2013 meeting
28/11/14		418KB	Share
VHL Results of Meeting - 2012 meeting
28/11/14		146.43KB	Share
VHL VHL boosts leadership with key chair and board appointments
28/11/14		184.14KB	Share
VHL Virax Shareholder Newsletter
07/11/14		1.32MB	Share
VHL Annual Report to shareholders
03/11/14		1.28MB	Share
VHL Appendix 4C - quarterly
03/11/14	PRICE SENSITIVE	241.39KB	Share
VHL ASX Grants Waiver - Listing Rule 10.13.3
31/10/14		440.1KB	Share
VHL Company overview brochure
30/10/14		144.18KB	Share
VHL Notice of AGM, including Independent Experts Report
30/10/14		973.78KB	Share
VHL Notice of Annual General Meeting/Proxy Form
29/10/14		581.8KB	Share
VHL Notices of AGM in relation to the 2012 and 2013 years
29/10/14		772.26KB	Share
VHL Roadshow Presentation
28/10/14		2.27MB	Share
VHL Video Presentation with Managing Director
17/10/14		430.94KB	Share
VHL VHL TO ACQUIRE DEEP AKT INHIBITOR PORTFOLIO
17/10/14	PRICE SENSITIVE	517.4KB	Share
VHL Trading Halt Request
15/10/14		434.08KB	Share
VHL Trading Halt
15/10/14	PRICE SENSITIVE	135.24KB	Share
VHL Multiple Myeloma Authority Joins Scientific Advisory Board
23/09/14		456.41KB	Share
VHL FDA IND Re-Activation Request for Phase Ib/II Trial
09/09/14	PRICE SENSITIVE	441.65KB	Share
VHL Virax Holdings Appendix 4E and 2014 Financial Report
01/09/14	PRICE SENSITIVE	1.44MB	Share
VHL Appendix 4C - quarterly
31/07/14	PRICE SENSITIVE	245.63KB	Share
VHL Investor Roadshow Presentation
23/07/14		3.43MB	Share
VHL Cancer Authority to help Steer US Breast Cancer Progam
21/07/14		458.79KB	Share
VHL Initial Director's Interest Notice
24/06/14		195.67KB	Share
VHL VHL appoints Ground Zero Pharmaceuticals
23/06/14		423.85KB	Share
VHL New MD to Present at International Life Sciences Showcase
16/06/14		426.6KB	Share
VHLInitial Director's Interest Notice
06/06/14		196.67KB	Share
VHLVHL completes Pathway acquisiton, appoints new director
30/05/14	PRICE SENSITIVE	476.89KB	Share
VHLAppendix 3B
30/05/14		541.98KB	Share
VHLAppendix 3B
20/05/14		931.87KB	Share
VHLAppointment of Managing Director to Drive Cancer Programs
15/05/14	PRICE SENSITIVE	497.36KB	Share
VHLAppendix 3B
15/05/14		542.14KB	Share
VHLDisclosure Document
14/05/14	PRICE SENSITIVE	835.15KB	Share
VHLCapital Raising Update
09/05/14	PRICE SENSITIVE	427.69KB	Share
VHLResults of Meeting
09/05/14		434.42KB	Share
VHLChairman's Address at General Meeting
09/05/14		169.01KB	Share
VHLInvestor Newsletter
06/05/14		552.49KB	Share
VHLVirax Option to Acquire Exclusive Worldwide Licence
05/05/14	PRICE SENSITIVE	472.87KB	Share
VHLTrading Halt
01/05/14	PRICE SENSITIVE	528.37KB	Share
VHLAppendix 4C - quarterly
30/04/14	PRICE SENSITIVE	239.03KB	Share
VHLAppointment of Gene Tech expert to further develop assets
29/04/14		464.78KB	Share
VHLCo-X-Gene Development Pipeline
24/04/14	PRICE SENSITIVE	452.49KB	Share
VHLNotice of General Meeting/Proxy Form
08/04/14		236.89KB	Share
VHLASX Grants Waivers - Listing Rule 7.3.2
03/04/14		458.64KB	Share
VHLAppendix 3B
27/03/14		541.54KB	Share
VHLVirax secures $3 million placement
25/03/14	PRICE SENSITIVE	475.51KB	Share
VHLTrading Halt
21/03/14	PRICE SENSITIVE	514.73KB	Share
VHLInvestor presentation
17/03/14		1.42MB	Share
VHLVirax to acquire advanced cancer platform from Yale Uni
17/03/14	PRICE SENSITIVE	503.67KB	Share
VHLTrading Halt
14/03/14	PRICE SENSITIVE	515.27KB	Share
VHLHalf Yearly Report and Accounts
28/02/14	PRICE SENSITIVE	701.92KB	Share
VHLIntellectual Property Report Update
19/02/14	PRICE SENSITIVE	456.31KB	Share
VHLAppendix 3B
18/02/14		541.51KB	Share
VHLResponse to ASX Aware Letter
12/02/14	PRICE SENSITIVE	664.29KB	Share
VHLTransgene Announces Topline Preliminary Results
07/02/14	PRICE SENSITIVE	558.04KB	Share
VHLAppendix 3B
11/12/13		541.54KB	Share
VHLCompany Update
05/12/13		548.72KB	Share
VHLReinstatement to Offical Quotation
19/11/13		424.27KB	Share
VHLResponse to ASX Appendix 3Z Query
19/11/13		546.56KB	Share
VHLASX Circular - Reinstatement to Official Quotation
18/11/13		84.19KB	Share
VHLReinstatement to Official Quotation - 19 November 2013
18/11/13	PRICE SENSITIVE	77.99KB	Share
VHLPre-quotation disclosures
14/11/13		1MB	Share
VHLRetirement of Deed Administrator
14/11/13		426.23KB	Share
VHLAnnual Report for the Year Ended 30 June 2013
14/11/13		1.22MB	Share
VHLHalf Yearly Report for the period ended 31 December 2012
14/11/13		411.68KB	Share
VHLAnnual Report for the Year Ended 30 June 2012
14/11/13		1.79MB	Share
VHLAdministrator/Receiver ??? Appointed/Removed
13/11/13		20.88KB	Share
VHLChange of Director's Interest Notices
29/10/13		1.16MB	Share
VHLFinal Director's Interest Notices
29/10/13		1.14MB	Share
VHLCompletion of Recapitalisation Proposal
25/10/13		458.96KB	Share
VHLCompany Secretary Appointment/Resignation
21/10/13		456.56KB	Share
VHLChange in substantial holding
10/10/13		76.13KB	Share
VHLAppendix 3B
25/09/13		514.89KB	Share
VHLProspectus
19/09/13		524.46KB	Share
VHLAnnouncement of Updated Constitution
03/09/13		49.9KB	Share
VHLHeader Corr: Consolidation process as approved by Sh'holders
03/09/13		36.6KB	Share
VHLAnnouncement of New Board/Appendix 3X Notices
03/09/13		181.74KB	Share
VHLInternal
03/09/13		62.21KB	Share
VHLResults of Meeting
02/09/13		203.82KB	Share
VHLDetails of Share Registry address
30/07/13		24.51KB	Share
VHLNotice of General Meeting
30/07/13		2.81MB	Share
VHLCompany Administration - Other
28/02/13		22.46KB	Share
VHLExecution of Deed of Company Arrangement
29/10/12		20.64KB	Share
VHLCompany Administration - Other
12/10/12		29.32KB	Share
VHLAppointment of Voluntary Administrators 24 August 2012
24/08/12		119.31KB	Share
VHLConvertible Note Quarterly Report 30 06 2012
31/07/12		244.62KB	Share
VHLAppendix 3B - 15 June 2012
15/06/12		293.77KB	Share
VHLRequest for Continuation of Suspension
15/06/12		142.16KB	Share
VHLTermination Share Purchase Agreement - 4G Vaccines Pty Ltd
15/06/12		101.73KB	Share
VHLCo-X-Gene Sub Licence and TG4001
14/05/12		207.14KB	Share
VHLConvertible Notes - Quarterly Report 31/3/2012
30/04/12		287.42KB	Share
VHLNoteholder General Meeting Results - 30 March 2012
30/03/12		185.68KB	Share
VHLNoteholder Notice of Meeting - 30 March 2012
15/03/12		1.46MB	Share
VHLAppendix 4D (31 December 2011)
14/03/12		9.76MB	Share
VHLAppointment of Director - Mr John Morrison - 13 March 2012
13/03/12		291.91KB	Share
VHLShare Purchase Agreement - 4G Vaccines 29 February 2012
01/03/12		178.84KB	Share
AAY +AKW CBP COJ EDS HAO KZL SLA MTM VHLSuspension from Official Quotation
01/03/12	PRICE SENSITIVE	16.4KB	Share
VHLConvertible Notes - Quarterly Report 31 December 2011
31/01/12		366.47KB	Share
VHLAppendix 3B - 10 January 2012
10/01/12		559.08KB	Share

REFRESH

First 5 6 7 8 9

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.6¢		Change 0.000(0.00%)		Mkt cap ! $44.68M

Open	High	Low	Value	Volume
2.6¢	2.6¢	2.4¢	$8.401K	342.2K

Buyers (Bids)

No.	Vol.	Price($)
8	1350432	2.4¢

Sellers (Offers)

Price($)	Vol.	No.
2.7¢	146386	2

View Market Depth

No.	Vol.	Price($)
7	1050433	0.024
5	1074000	0.023
5	581000	0.022
7	713423	0.021
2	400000	0.020

Price($)	Vol.	No.
0.027	146386	2
0.028	497220	3
0.029	510563	2
0.030	984470	6
0.031	1222858	4

Last trade - 15.20pm 08/08/2025 (20 minute delay)

VHL (ASX) Chart

VITASORA HEALTH LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available